Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention.
Journal: Emerging infectious diseases
Published: April 26, 2024
Crimean Congo Hemorrhagic Fever Virus for Clinicians-Virology, Pathogenesis, and Pathology.
Journal: Emerging infectious diseases
Published: April 26, 2024
Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Diagnosis, Clinical Management, and Therapeutics.
Journal: Emerging infectious diseases
Published: April 26, 2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 23, 2024
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial.
Journal: The Lancet. Microbe
Published: September 25, 2023
Lassa Virus Infection: a Summary for Clinicians.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 18, 2022
Pediatric Osteoarticular Infections Caused by Mycobacteria Tuberculosis Complex: A 26-Year Review of Cases in San Diego, CA.
Journal: The Pediatric infectious disease journal
Published: January 02, 2022
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Journal: The Lancet. Infectious diseases
Published: October 08, 2021
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum.
Journal: The Journal of infectious diseases
Published: October 02, 2021
SARS-CoV-2 Among Infants <90 Days of Age Admitted for Serious Bacterial Infection Evaluation.
Journal: Pediatrics
Published: June 15, 2021
Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Journal: Nature
Published: January 20, 2021
Last Updated: 09/26/2026